Press Releases Latest Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders Press Releases Year None202420232022202120202019201820172016201520142013 Dec 13, 2019 Theratechnologies’ Oncology Platform Improves Efficacy and Tolerability of Docetaxel In Vivo and In Vitro Nov 27, 2019 Theratechnologies’ CFO to Attend Piper Jaffray 31st Annual Healthcare Conference in New York City Nov 25, 2019 Theratechnologies Starts Commercialization of New EGRIFTA SV™ in the United States Nov 14, 2019 Theratechnologies’ CFO to Attend Stifel Healthcare Conference in New York City Nov 07, 2019 Trogarzo® Remains Effective Close to a Decade After Treatment Initiation Oct 21, 2019 Theratechnologies Provides Details About R&D Day Webcast Oct 11, 2019 Tesamorelin Study Results On NAFLD Published in Lancet HIV Oct 10, 2019 Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing Oct 08, 2019 Theratechnologies Announces Financial Results for the Third Quarter of 2019 Oct 04, 2019 1.7 Million Dollar Grant Towards Development of Theratechnologies’ Targeted Oncology Platform First page « Previous page ‹ … Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Page 21 Page 22 … Next page › Last page » Displaying 171 - 180 of 360
Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
Dec 13, 2019 Theratechnologies’ Oncology Platform Improves Efficacy and Tolerability of Docetaxel In Vivo and In Vitro
Nov 27, 2019 Theratechnologies’ CFO to Attend Piper Jaffray 31st Annual Healthcare Conference in New York City
Oct 10, 2019 Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing
Oct 04, 2019 1.7 Million Dollar Grant Towards Development of Theratechnologies’ Targeted Oncology Platform